Search Orphan Drug Designations and Approvals
-
Generic Name: | capsaicin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Qutenza | ||||||||||||||||
Date Designated: | 05/22/2009 | ||||||||||||||||
Orphan Designation: | Management of neuropathic pain in patients with postherpetic neuralgia | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Averitas Pharma, Inc. 360 Mount Kemble Avenue Morristown, New Jersey 07960 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | capsaicin |
---|---|---|
Trade Name: | Qutenza | |
Marketing Approval Date: | 11/16/2009 | |
Approved Labeled Indication: | Management of neuropathic pain associated with postherpetic neuralgia | |
Exclusivity End Date: | 11/16/2016 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-